VEGFA and hepatocellular carcinoma: These findings are in contrast to various available reports performed in the setting of liver resection and locoregional therapies for HCC, where high serum VEGF levels seemed to correlate strongly with poor prognostic features such as absence of tumor capsule, presence of intrahepatic metastases, microvascular invasion and more advanced stages of disease [29,30,37,40].